Ilex acquires Symphar for $30M

ILXO acquired Symphar, a Geneva-based medicinal chemistry company, for $15 million in

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE